COLO B Coloplast A/S Class B

Coloplast Launches New Catheter in the U.S.

Coloplast Launches New Catheter in the U.S.

Coloplast’s SpeediCath® Flex Set catheter developed for people living with bladder and urinary problems is now cleared in the U.S. and will be launched in November 2022.  

The new SpeediCath Flex Set with a “no touch dry sleeve” and an omni-directional tip is available as a catheter and bag solution, also called a Closed System. All SpeediCath® catheters feature Triple Action Coating Technology which is designed to reduce the risk of urethral damage and Urinary Tract Infections (UTIs)*1 and are an option for those with spinal cord injuries (SCI).

“With SpeediCath Flex Set, we are introducing an important solution for people living with SCI and many other health conditions. We are confident that its new innovative design will make a big difference to our users, improving their catheterization routine in many ways,” says Senior Vice President Manu Varma, Chronic Care in North America.

A recent estimate2 shows that the annual incidence of SCI is about 18,000 cases each year in the U.S. and the majority of the SCI patients will suffer from Neurogenic Bladder Dysfunction (NBD). Patients with NBD have significant challenges to their well-being, ranging from incontinence, renal impairment, and urinary tract infections to bladder stones and a generally poor quality of life.3

The SpeediCath Flex Set is a gentle, all-in-one solution. It has features that help patients confidently catheterize at home or away, supporting them in managing their condition and maintaining a healthy lifestyle. Find more information about SpeediCath Flex Set .

About Coloplast’s Continence Care Products 

Coloplast aims to deliver effective solutions for bladder and bowel control. By continuously gathering feedback from clinicians and patients, the company innovates to solve urinary problems such as incontinence and retention. Coloplast also offers additional support through its Coloplast® Care program, which provides product and lifestyle advice, inspiration, and education resources for people living with bladder issues.

About Coloplast 

Danish medical device company Coloplast develops products and services designed to make life easier for people with intimate health conditions. Coloplast listens to end-users to better understand their needs and responds by bringing the best ideas to market in the form of medical devices and service solutions. Visit for more information. 

 



This information is intended to be an educational resource and presented for general information purposes only. It is not intended to constitute medical or business advice or in any way replace the independent medical judgment of a trained and licensed physician with respect to any patient needs or circumstances. Prior to use, please refer to the product ‘Instructions for Use’ for the intended use and relevant safety information.

* Compared to uncoated catheters

  1. Rognoni C, Tarricone R. Intermittent catheterization with hydrophilic and non-hydrophilic urinary catheters: systematic literature review and meta-analyses. BMC Urol. 2017 Jan 10;17(1):4. doi: 10.1186/s12894-016-0191-1.PMID: 28073354; PMCID: PMC5225586.
  2. The National Spinal Cord Injury Database, 2020 SCI Datasheet

Global press contact 

Peter Mønster, Senior Media Relations Manager 

 



    

U.S. press contact 

Kate Merwin, Head of Communications 

612-286-2455 

 



EN
18/11/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

 PRESS RELEASE

Coloplast A/S - Opdateret finanskalender 2025-26

Coloplast A/S - Opdateret finanskalender 2025-26 Venligst se vedlagte pdf.  Opdatering af datoer i finanskalenderen Coloplast har opdateret datoerne i selskabets finanskalender vedrørende offentliggørelsen af årsregnskabet for 2025/26 samt afholdelsen af den ordinære generalforsamling 2026. De opdaterede datoer er som følger: Årsregnskabsmeddelelse for 2025/26 og Årsrapport 2025/26: ændret fra 5. november 2026 til 3. november 2026Ordinær generalforsamling 2026: ændret fra 3. december 2026 til 1. december 2026 For yderligere information og kalenderinvitationer til kommende beg...

 PRESS RELEASE

Coloplast A/S - Updated Financial Calendar 2025-26

Coloplast A/S - Updated Financial Calendar 2025-26 Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual General Meeting 2026.  The updated dates are as follows: Financial Statements for the full year 2025/26 and Annual Report 2025/26: changed from November 5, 2026 to November 3, 2026Annual General Meeting 2026: changed from December 3, 2026 to December 1, 2026 For more information and calendar invitations for upcoming events, please visit:   Kind...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen

ResearchPool Subscriptions

Get the most out of your insights

Get in touch